Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer
Clinical trial NCT04590625 · UNKNOWN
Trial details
- NCT number
- NCT04590625
- Sponsor
- Zhongshan Hospital Xiamen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-10-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.